The Dallas-Fort Worth Hospital Council (DFWHC) is pleased to announce ELEVATE340B has become a member of its team effective immediately. The partnership is expected to enhance the value DFWHC offers its hospital members through savings optimization programs and education provided by ELEVATE340B.
“This partnership continues a long-standing DFWHC trend to team with select companies that provide valuable services to our members,” said W. Stephen Love, president/CEO of DFWHC. “In this case, 340B hospitals could potentially receive great financial benefits. We consider partnership proposals on a weekly basis and realized almost immediately ELEVATE340B would be a valuable resource.”
ELEVATE340B is a savings optimization program for 340B-covered entities. Such entities face challenges controlling WAC, GPO and Orphan drug spending. Pharmacists and 340B coordinators primarily dedicate their resources to program maintenance and compliance, oftentimes lacking the time for regular, account/patient-level detailed optimization reviews. ELEVATE340B provides consultative monitoring to identify opportunities to optimize 340B program drug purchases in a compliant manner.
“We are very pleased to partner with DFWHC,” said Michael Newell, President of ELEVATE340B. “Given our data analytics background coupled with the subject matter expertise of our pharmacy team, we are able to assist 340B programs with their optimization challenges so they can ultimately focus on their mission to deliver quality patient care.”
ELEVATE340B is a joint-venture powered by Southwest Consulting Associates and Turnkey Pharmacy Solutions and is headquartered in Plano, Texas. The combined entities have over 700 hospital clients nationally, have conducted over 250 340B compliance audits over the last two years and provided guidance to approximately 20 clients during HRSA audits in addition to thousands of optimization engagements since their inception.